Eli Lilly stock jumps on earnings beat
Digest more
Eli Lilly is a leader in one of today’s biggest growth markets: weight loss drugs. The company recently won approval for an ...
Eli Lilly and Company (NYSE:LLY) was among the stocks Jim Cramer highlighted, as he discussed the massive AI infrastructure ...
Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and Drug ...
Stocktwits on MSN
Eli Lilly’s been on an acquisition spree this year – here’s a look at its major deals
Eli Lilly notched up its sixth acquisition this year with the buyout of Ajax Therapeutics for $2.3 billion. ・Other ...
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that ...
I think it’s suffice for me to say that investors in Eli Lilly (LLY) really needed this strong earnings slate that it ...
Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill.
Eli Lilly shares jumped after the drugmaker posted earnings that topped estimates and hiked its outlook, thanks to booming ...
CNBC’s Fast Money panel recently made a notable pivot on its April 24 episode, arguing that Novo Nordisk (NYSE:NVO) now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results